Skip to content

KDK KDK Loss on issuance of equity instruments

Loss on issuance of equity instruments at other companies

Globalstar logo
GlobalstarGSAT
$0
Navan, Inc.
 logo
Navan, Inc. NAVN
$0+100%
Ashland logo
AshlandASH
$0
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
-$49.23M
Cinemark Holdings logo
Cinemark HoldingsCNK
$0
Alpha and Omega Semiconductor logo
Alpha and Omega SemiconductorAOSL
-$19.45M-1,525%

Other financials

Income statement

See full
Revenue$1.8M+24.4%
Operating income-$37.9M-104%
Net income$26.5M+121%
EPS (diluted)$0.10+105%

Balance sheet

See full
Cash & equivalents$66.4M+247%
Total debt$58.4M+1,068%
Total equity-$245.9M+34.7%
Total assets$130.8M-76.5%

Cash flow

See full
Operating cash flow-$29.5M-78.7%
CapEx$5.5M+138%
Free cash flow-$35.0M-86.0%

Valuation

See full
Market cap$1.05B-18.6%
Enterprise value$1.04B
P/S252.8×

Profitability

See full
Operating margin-2,695.8%
Net margin-10,366.9%
FCF margin-278%

Returns & leverage

See full
Return on equity-21.5%
Debt / equity-0.2×
Current ratio3.7×+3.4×

Where this comes from

Reported directly by KDK in its filing.

Tagged under the XBRL concept kdk:GainLossOnIssuanceOfEquityInstruments.

The official record: KDK’s 10-K, filed March 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about KDK's loss on issuance of equity instruments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KDK's loss on issuance of equity instruments?
KDK (KDK) reported loss on issuance of equity instruments of -$52.68M in Q4 2025.
What does loss on issuance of equity instruments mean?
This metric reflects the accounting impact of issuing equity-linked instruments, such as warrants or options, often measured at fair value upon issuance. It highlights the non-cash financial consequences of capital structure decisions and the cost of equity financing arrangements.